Evidence map›Paper›PMID 31562612›Full record

ArticleDigestive diseases and sciences2020

GADD45G Interacts with E-cadherin to Suppress the Migration and Invasion of Esophageal Squamous Cell Carcinoma.

Tongtong Li, Lele Xu, Jinglei Teng, Yunping Ma, Wenzhong Liu, Yan Wang, Xinming Chi, Shujuan Shao, Yan Dong, Qimin Zhan and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Digestive diseases and sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. GADD45 in Stress Signaling, Cell Cycle Control, and Apoptosis.Advances in experimental medicine and biology · 2022
    Article
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 3 countries.

Tongtong LiInstitute of Cancer Stem Cell, Dalian Medical University, No. 9 West Section, Lvshun South Road, Lvshunkou District, Dalian, 116044, China.
Lele XuInstitute of Cancer Stem Cell, Dalian Medical University, No. 9 West Section, Lvshun South Road, Lvshunkou District, Dalian, 116044, China.
Jinglei TengInstitute of Cancer Stem Cell, Dalian Medical University, No. 9 West Section, Lvshun South Road, Lvshunkou District, Dalian, 116044, China.
Yunping MaInstitute of Cancer Stem Cell, Dalian Medical University, No. 9 West Section, Lvshun South Road, Lvshunkou District, Dalian, 116044, China.
Wenzhong LiuInstitute of Cancer Stem Cell, Dalian Medical University, No. 9 West Section, Lvshun South Road, Lvshunkou District, Dalian, 116044, China.
Yan WangKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Laboratory of Molecular Oncology, Peking University Cancer Hospital & Institute, No. 52 Fucheng Road, Haidian District, Beijing, 100142, China.
Xinming ChiLiaoning Key Laboratory of Proteomics, Dalian Medical University, No. 9 West Section, Lvshun South Road, Lvshunkou District, Dalian, 116044, China.
Shujuan ShaoLiaoning Key Laboratory of Proteomics, Dalian Medical University, No. 9 West Section, Lvshun South Road, Lvshunkou District, Dalian, 116044, China.
Yan DongCollege of Stomatology, Dalian Medical University, No. 9 West Section, Lvshun South Road, Lvshunkou District, Dalian, 116044, China.
Qimin ZhanInstitute of Cancer Stem Cell, Dalian Medical University, No. 9 West Section, Lvshun South Road, Lvshunkou District, Dalian, 116044, China.
Xuefeng LiuInstitute of Cancer Stem Cell, Dalian Medical University, No. 9 West Section, Lvshun South Road, Lvshunkou District, Dalian, 116044, China. ixuee@sina.com.ORCID 0000-0002-4991-9080
Dalian Medical University · CNPeking University · CN

Funding

Education Department of Liaoning Province in China (Scientific Research Projects) L2016038National Basic Research Program of China (973 Program) 2015CB553904National Basic Research Program of China (973 Program) 2015CB553906National Natural Science Foundation of China 81402283National Natural Science Foundation of China 81490753National Natural Science Foundation of China 81830086Natural Science Foundation of Liaoning 2015020304
6 · The paper itself

Abstract

BACKGROUND/

aimsEsophageal squamous cell carcinoma (ESCC) is one of the most prevalent cancers with poor prognosis. Metastasis is the leading cause of cancer-related deaths. The growth arrest and DNA damage-inducible 45 gamma (GADD45G) has been reported to correlate with survival, invasion, and metastasis of ESCC. This study was aimed to investigate the role and mechanism of GADD45G in ESCC cell migration and invasion.

methodsBoth the effects of GADD45G and its need for E-cadherin to function on ESCC cell migration and invasion were determined through loss- and gain-of-function approaches via Transwell assays. The interaction between GADD45G and E-cadherin was detected by GST-pull down and IP assays. The expression of E-cadherin upon GADD45G overexpression was evaluated by RT-qPCR and western blot. The level of E-cadherin in cytoplasmic, nuclear, and membrane fractions was examined by western blot following subcellular fractionation.

resultsKnockdown of GADD45G increased the migration and invasion abilities of KYSE150 cells, while overexpression of GADD45G showed the opposite effects on YES2 and KYSE30 cells. GADD45G could interact with E-cadherin and enhanced its membrane level. Knockdown of E-cadherin abolished the inhibitory effects of GADD45G on ESCC cell migration and invasion. Intriguingly, dimer-dissociating mutant of GADD45G could not interact with E-cadherin and almost lost its ability to suppress the ESCC cell migration and invasion.

conclusionsThis study reveals a novel role for GADD45G in inhibiting the ESCC cell migration and invasion, which will provide a new insight in understanding the ESCC metastatic mechanism.

Indexed as

Antigens, CDBiomarkers, TumorCadherinsCell Line, TumorCell MovementEsophageal NeoplasmsEsophageal Squamous Cell CarcinomaGADD45 ProteinsGene Knockdown TechniquesHEK293 CellsHumansIntracellular Signaling Peptides and ProteinsNeoplasm InvasivenessProtein BindingAntigens, CDBiomarkers, TumorCadherinsCDH1 protein, humanGADD45G protein, humanGADD45 ProteinsIntracellular Signaling Peptides and ProteinsE-cadherinESCCGADD45GInvasionMigration

Identifiers

PMID31562612
OpenAlexW2975324340

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.